Donanemab vs Imatinib

## Donanemab vs Imatinib: Overview

This comparison examines the pharmacological differences between **Donanemab** and **Imatinib**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

## Pharmacokinetics

**Half-life**: Donanemab — N/A; Imatinib — 18 hours.

## Chemical Properties

**Molecular Formula**: Donanemab — N/A; Imatinib — C29H31N7O.

**Molecular Weight**: Donanemab — N/A; Imatinib — 493.6030 g/mol.

**Type**: Donanemab — Antibody; Imatinib — Small molecule.